Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.20933 | 49 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.13251 | 48 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.13578 | 48 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.03363 | 46 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.07724 | 48 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.30788 | 50 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.27786 | 50 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.10508 | 47 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.06918 | 46 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.09216 | 47 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.19073 | 50 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.10524 | 48 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.1554 | 48 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.1232 | 48 |